Related Experiment Video
Updated: Jun 8, 2026
06:51
Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
[Fluorodeoxyglucose F18(FDG)-probe guided biopsy].
Koen J Hartemink1, Sandra Muller, Yvo M Smulders
1VU Medisch Centrum, Amsterdam, Afd. Chirurgie, the Netherlands. kjhartemink@hetnet.nl
Nederlands Tijdschrift Voor Geneeskunde
|September 23, 2010
Summary
Fluorodeoxyglucose F18 (FDG)-probe guided surgery helps surgeons precisely locate and resect FDG-avid lesions, improving diagnostic accuracy and reducing non-representative tissue removal.
Area of Science:
- Nuclear Medicine
- Surgical Oncology
Background:
- Positron emission tomography-computed tomography (PET-CT) enhances diagnosis but often requires histopathology.
- Some lesions are visible on PET scans (e.g., with fluorodeoxyglucose F18 [FDG]) but not conventional imaging.
- Percutaneous biopsy may be challenging due to lesion location or size.
Purpose of the Study:
- To evaluate the utility of FDG-probe guided surgery for lesion detection and resection.
- To assess the impact of this technique on diagnostic accuracy and tissue sampling.
Main Methods:
- Surgeons utilize an FDG-sensitive probe during surgery to identify FDG-avid lesions.
- The probe guides intraoperative detection and excision of these lesions for histopathological analysis.
Main Results:
- FDG-probe guided surgery enables peroperative detection of FDG-avid lesions.
- This technique minimizes the removal of non-representative tissue.
- It aids in localizing lesions for complete resection and potentially increases diagnostic sensitivity.
Conclusions:
- FDG-probe guided surgery is a valuable tool for enhancing the precision of diagnostic resections.
- It offers improved localization of FDG-avid lesions, especially when conventional imaging is insufficient or percutaneous access is difficult.
